Heart Surgery
ABLATE-PASSThe primary objective of this post-approval study is to evaluate the clinical outcomes in a cohort of patients with non-paroxysmal forms of atrial fibrillation (persistent or long-standing persistent) treated during commercial use of the AtriCure Synergy Ablation System by physicians performed the Maze IV procedure. Principal Investigator: Michael Moront, MD Contact the research coordinator: Tamithy Huber, RN at 419-291-5757 M13-796This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery. Principal Investigator: Michael Moront, MD Contact the research coordinator: Tamithy Huber, RN at 419-291-5757 |



















